Recent Updates
Recently added Catalysts
SIBN Positive Sentiment

SI-BONE To Present at Piper Sandler 38th Annual Healthcare Conference on December 1, 2026

Key Takeaway: SI-BONE, Inc. will participate in the Piper Sandler 38th Annual Healthcare Conference on December 1, 2026. The company will host a fireside chat at 5:00 a.m. PT. Investors can register to listen live or access the archived webcast on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • SI-BONE will present at a major healthcare conference.
  • The company has a strong track record with over 160,000 procedures.
  • SI-BONE has built a technology platform with market-leading applications.

Full Press Release Details

SAN JOSE, Calif., Nov. 19, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming Piper Sandler 38th Annual Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Tuesday, December 1, 2026, at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: SI-BONE, Inc. (SIBN) - 1781908. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone. With expertise in biomechanical design and anatomy specific innovation, SI-BONE has built a technology platform with market-leading applications centered on the spinopelvic anatomy. SI-BONE continues to leverage the deep experience in addressing the challenges of low-density bone in the sacrum to develop unique technologies that are targeting new clinical adjacencies to help improve outcomes for patients with compromised bone. Since 2009, SI-BONE has supported physicians in over 160,000 procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including four randomized controlled trials and nearly 200 peer-reviewed publications.
For additional information on the company or the products, including risks and benefits, please visit www.si-bone.com.
SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved.

Investor Contact: Saqib Iqbal, investors@si-bone.com

Frequently Asked Questions

When will SI-BONE present at the conference?

SI-BONE will present on December 1, 2026, at 5:00 a.m. PT.

How can I listen to the conference call?

Investors can register to listen via the SI-BONE website.

What is SI-BONE known for?

SI-BONE is a leader in developing solutions for compromised bone.

How many procedures has SI-BONE supported?

SI-BONE has supported over 160,000 procedures since 2009.

Last updated: Nov 19, 2026